General Information of the Compound
| Compound ID |
CP0386009
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[2-[[(2S,5S,8R,12R)-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-3,6,11,14-tetraoxo-1,4,7,10-tetrazacyclotetradec-12-yl]amino]-2-oxoethyl]piperidine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H48N8O6
|
||||||||||||||||||
| Molecular Weight |
748.885
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)C1CCN(CC(=O)N[C@@H]2CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@H](Cc3ccccc3)CNC2=O)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H48N8O6/c42-38(52)28-15-17-49(18-16-28)25-37(51)47-35-22-36(50)46-34(21-29-23-43-32-14-8-7-13-31(29)32)41(55)48-33(20-27-11-5-2-6-12-27)40(54)45-30(24-44-39(35)53)19-26-9-3-1-4-10-26/h1-14,23,28,30,33-35,43H,15-22,24-25H2,(H2,42,52)(H,44,53)(H,45,54)(H,46,50)(H,47,51)(H,48,55)/t30-,33+,34+,35-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HHGHXNWCIDSTKU-WNWUTZSISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound